▲ Peaking
Business
All eyes on data on Biogen’s tau therapy
Biogen's experimental anti-tau therapy shows promise in slowing cognitive decline for early Alzheimer's patients.
1 news trends Newsylist has tracked involving CELIA Data — newest first.
Biogen's experimental anti-tau therapy shows promise in slowing cognitive decline for early Alzheimer's patients.